Nilotinib is superior to imatinib as first-line therapy of chronic myeloid leukemia: the ENESTnd study
Year: 2010
Type: article
Source: Expert Review of Hematology
DOI: 10.1586/ehm.10.61
Institutions: National University of Ireland, Ollscoil na Gaillimhe – University of Galway, Trinity College Dublin, IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola, University of Bologna, Laiko General Hospital of Athens, Royal Liverpool University Hospital, Charité – Universitätsmedizin Berlin, Inserm, Centre Hospitalier Universitaire de Bordeaux, Université Bordeaux Segalen, Hospital Universitario de La Princesa, Medical University of Vienna, University of Turin
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1999832647